MedPath
HSA Approval

SUNTACID TABLET

SIN07066P

SUNTACID TABLET

SUNTACID TABLET

June 18, 1992

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AF02

ordinary salt combinations and antiflatulents

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

ALUMINIUM HYDROXIDE

250 mg

Aluminum hydroxide

SIMETHICONE

30 mg

Simethicone

MAGNESIUM TRISILICATE

250 mg

Magnesium trisilicate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUNTACID TABLET - HSA Approval | MedPath